Moderna
MRNA
#1188
Rank
S$20.54 B
Marketcap
$53.38
Share price
-0.43%
Change (1 day)
-53.50%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$20.54 Billion

As of December 2024 Moderna has a market cap of S$20.54 Billion. This makes Moderna the world's 1188th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024S$20.54 B-58.98%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of Moderna was reported to be:

S$20.54 Billion
by Yahoo Finance info icon info icon
S$20.54 Billion
by CompaniesMarketCap info icon info icon
S$20.54 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$0.14 B-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$336.10 B 1,536.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.12 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$42.89 B 108.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$263.09 B 1,180.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$3.27 B-84.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$471.34 B 2,194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.03 B-80.36%๐Ÿ‡บ๐Ÿ‡ธ USA